MarketsandMarkets Presents
Breast Biopsy Industry is Projected to be Worth $728.8 Million by 2020 http://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
The report Breast Biopsy Market by Product (Table, Needle, Localization wire, Guidance System), by Type (Open Biopsy- Excisional, Incisional, Needle- Core Needle Aspiration, Vacuum Assisted) & by Guidance system (Ultrasound, Stereotactic, MRI) - Forecast to 2020 , provides a detailed overview of major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global market along with estimates and forecast of revenue. Browse 75 market data tables 66 figures 152 pages and in-depth TOC on ÍžBreast Biopsy MarketÍ&#x; Request for Customization: http://www.marketsandmarkets.com/requestCustomization.asp?id=189011805 The global breast biopsy market is poised to reach $728.8 Million by 2020 from $436.4 Million in 2015, at a CAGR of 10.8% from 2015 to 2020.
http://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
Factors such as increased breast cancer screening programs in different countries, the rising incidence of breast cancer among women, increased reimbursement rates in the
U.S. for image-guided biopsies, and the increasing demand for less-invasive breast biopsies are the key factors driving the growth of the breast biopsy market.
Inquiry Before Buying: http://www.marketsandmarkets.com/requestCustomization.asp?id=189011805 However, the risk of infection due to improper care of breast biopsy cuts and wounds and
uncertain regulatory approval procedures for medical devices are likely to restrain the growth of the market.
http://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
The market is segmented on the basis of product, type, guidance, and region. The breast biopsy guidance market is categorized into mammography, ultrasound, MRI, and others (PET and thermography). In this market, the ultrasound segment is expected to be the fastest growing owing to the increasing demand for minimally invasive and non-radiation breast biopsy among patients and surgeons. Get the Sample Pages@ http://www.marketsandmarkets.com/requestsample.asp?id=189011805 On the basis of type, the market is classified into needle and open surgical breast biopsy market. The needle breast biopsy segment is expected to account for the largest share of the global breast biopsy market. The large share of this segment can be attributed to the increased preference for needle biopsies over open surgical breast biopsies and the demand for scar-less and painless surgical procedures.
http://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
On the basis of region, the breast biopsy market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America is expected to account for the largest share of the breast biopsy market, followed by Europe.
However, Asia-Pacific is expected to register a higher growth rate during the forecast period.
The growth of the breast biopsy market in Asia-Pacific will be centered on China and India.
Major players operating in the breast biopsy market are Becton, Dickinson and Company (U.S.), C.R. Bard, Inc. (U.S.), Devicor Medical Products Inc. (U.S.), and Hologic Inc. (U.S.).
http://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
About MarketsandMarkets™ Marketsa dMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide co pa ies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach Marketsa dMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at Marketsa dMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. Marketsa dMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. . Marketsa dMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
http://www.marketsandmarkets.com/Market-Reports/biopsy-devices-breast-biopsy-market189011805.html
Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets